Related Experiment Video

Updated: Apr 7, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K

Natural Killer cell control of BRAF mutant melanoma during targeted therapy

Lucas Ferrari de Andrade1, Shin Foong Ngiow2, Ludovic Martinet3

  • 1Immunology in Cancer and Infection Laboratory; QIMR Berghofer Medical Research Institute ; Herston, Queensland, Australia ; Current appointment - Department of Cancer Immunology and AIDS; Dana-Farber Cancer Institute ; Boston, Massachusetts, USA.

Oncoimmunology
|July 3, 2015
PubMed

Insights

Targeting BRAFV600E in melanoma shows initial responses but lacks durability. Natural Killer (NK) cells are key to BRAF inhibitor efficacy against melanoma metastases, offering a potential therapeutic strategy.

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Background:

  • Advanced BRAFV600E melanoma exhibits high response rates to targeted BRAF inhibition.
  • Durable responses remain a challenge in BRAF-mutant melanoma treatment.
  • Natural Killer (NK) cells have emerged as critical players in anti-tumor immunity.

Purpose of the Study:

  • To investigate the role of Natural Killer (NK) cells in the efficacy of BRAF inhibitors against melanoma.
  • To explore the therapeutic potential of exploiting NK cell activity to overcome BRAF inhibitor resistance in melanoma.

Main Methods:

  • Utilized a mouse model of BRAFV600E melanoma metastasis.
  • Administered pharmacologic BRAF inhibitors.
  • Assessed the role of NK cells in tumor control and drug response.

Main Results:

  • Pharmacologic BRAF inhibition showed limited durable responses in advanced melanoma.
  • NK cells were found to be essential for BRAF inhibitor-mediated control of melanoma metastases in preclinical models.
  • The study suggests NK cell activity is a critical factor in the therapeutic success of BRAF inhibitors.

Conclusions:

  • NK cells play a crucial role in the anti-metastatic effects of BRAF inhibitors in melanoma.
  • Therapeutic strategies aimed at enhancing NK cell function may overcome resistance to BRAF inhibitors in melanoma patients.
  • Targeting NK cell-mediated immunity presents a promising avenue for improving durable responses in BRAF-mutant melanoma.
Keywords:
BRAFNK cellscancer immunotherapymetastasesresistance

More Related Videos

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

3.5K
A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.4K